Advertisement

Current Anesthesiology Reports

, Volume 8, Issue 2, pp 130–133 | Cite as

Qualitative Neuromuscular Monitoring: Patterns of Stimulation, Site of Monitoring, and Accuracy in Detecting Residual Neuromuscular Blockade

  • Moumen Asbahi
  • Roy Soto
Neuromuscular Blockade (GS Murphy, Section Editor)
  • 50 Downloads
Part of the following topical collections:
  1. Neuromuscular Blockade

Abstract

Purpose of Review

Muscle paralysis is a component of many general anesthetics, and monitoring of neuromuscular function is integral to ensuring complete and safe recovery.

Recent Findings

Recommendations for qualitative neuromuscular blockade have been well-described in the literature for decades; however practitioners frequently do not follow recommendations, resulting in patient harm from inadequate reversal of paralysis.

Summary

This review will focus on evidence-based techniques for patterns of stimulation, sites of monitoring, and accuracy in detecting residual neuromuscular blockade; furthermore, the review will also discuss barriers to implementation of best practices.

Keywords

Paralysis Neuromuscular blockade Acetylcholinesterase inhibitor Neostigmine Edrophonium Glycopyrrolate Atropine Residual paralysis Postoperative residual curarization Sugammadex 

Notes

Compliance with Ethical Standards

Conflict of Interest

Moumen Asbahi and Roy Soto declare they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest have been highlighted as: • Of importance, •• Of outstanding importance

  1. 1.
    Bevan DR, Donati F, Kopman AF. Reversal of neuromuscular blockade. Anesthesiology. 1992;77:785–805.  https://doi.org/10.1097/00000542-199210000-00025.CrossRefPubMedGoogle Scholar
  2. 2.
    • Todd MM, Hindman BJ, King BJ. The implementation of quantitative electromyographic neuromuscular monitoring in an academic anesthesia department. Anesth Analg. 2014;119:323–31. Implementation of quantitative neuromuscular blockade monitoring resulted in a significant reduction in the incidence of incompletely reversed patients in the PACU.  https://doi.org/10.1213/ANE.0000000000000261.CrossRefPubMedGoogle Scholar
  3. 3.
    •• McLean DJ, Diaz-Gil D, Farhan HN, Ladha KS, Kurth T, Eikermann M. Dose-dependent association between intermediate-acting Neuromuscular-blocking agents and postoperative respiratory complications. Anesthesiology. 2015;122(6):1201–13. A study which shows a neuromuscular-blocking agent dose-dependent association with increased risk of respiratory complications in the postoperative period, and also suggesting that the proper use of neostigmine guided by neuromuscular transmission monitoring results can help eliminate postoperative respiratory complications associated with neuromuscular-blocking agents. CrossRefPubMedGoogle Scholar
  4. 4.
    Madsen MV, Staehr-Rye AK, Gatke MR, Claudis C. Neuromuscular blockade for optimising surgical conditions during abdominal and gynaecological surgery: a systematic review. Acta Anaesthesiol Scand. 2015;59:1–16.  https://doi.org/10.1111/aas.12419.CrossRefPubMedGoogle Scholar
  5. 5.
    Fuchs-Buder T, Hofmockel R, Geldner G, Diefenbach C, Ulm K, Blobner M. The use of neuromuscular monitoring in Germany. Anaethesitst. 2003,52–55-6.Google Scholar
  6. 6.
    Sasaki N1, Meyer MJ, Malviya SA, Stanislaus AB, MacDonald T, Doran ME, et al. Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes: a prospective study. Anesthesiology. 2014;121:959–68.CrossRefPubMedGoogle Scholar
  7. 7.
    Fuchs-Buder T, Meitelman C, Alla F, Grandjean A, Wuthrich Y, Donati F. Antagonism of low degrees of atracurium-induced neuromuscular blockade. Dose-effect relationships for neostigmine. Anesthesiology. 2010;112:34–40.  https://doi.org/10.1097/ALN.0b013e3181c53863.CrossRefPubMedGoogle Scholar
  8. 8.
    Fuchs-Buder T, Baumann C, De Guis J, Guerci P, Meistelman C. Low-dose neostigmine to antagonize shallow atracurium neuromuscular block during inhalational anaesthesia. A randomized controlled trial. Eur J Anaesth. 2013;30:594–8.  https://doi.org/10.1097/EJA.0b013e3283631652.CrossRefGoogle Scholar
  9. 9.
    Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg. 2010;111:110–9.  https://doi.org/10.1213/ANE.0b013e3181c07428.CrossRefPubMedGoogle Scholar
  10. 10.
    Grayling M, Sweeney BP. Recovery of neuromuscular blockade: a survey of practice. Anaesthesia. 2007;62:806–9.  https://doi.org/10.1111/j.1365-2044.2007.05101.x.CrossRefPubMedGoogle Scholar
  11. 11.
    Checketts MR, Alladi R, Ferguson K, et al. Recommendations for standards of monitoring during anaesthesia and recovery 2015: Association of Anaesthestists of Great Britain and Ireland. Anaesthesia. 2015;Google Scholar
  12. 12.
    Lien CA, Kopman AF. Current recommendations for monitoring depth of neuromuscular blockade. Curr Opin Anesthesiol. 2014;27:616–22.CrossRefGoogle Scholar
  13. 13.
    Brull S, Kopman A. Current status of neuromuscular reversal and monitoring: challenges and opportunities. Anesthesiology. 2017;126:173–90.  https://doi.org/10.1097/ALN.0000000000001409.CrossRefPubMedGoogle Scholar
  14. 14.
    Ortega R, Brull SJ, Prielipp R, Gutierrez A, De La Cruz R, Conley C. Monitoring neuromuscular function. N Engl J Med. 2018;378:e6.  https://doi.org/10.1056/NEJMvcm1603741.CrossRefPubMedGoogle Scholar
  15. 15.
    Thilen SR, Hansen BE, Ramaiah R, Kent CD, Treggiari MM, Bhananker SM. Intraoperative neuromuscular monitoring site and residual paralysis. Anesthesiology. 2012;117:964–72.  https://doi.org/10.1097/ALN.0b013e31826f8fdd.CrossRefPubMedGoogle Scholar
  16. 16.
    Kopman AF, Eikermann M. Antagonism of non-depolarising neuromuscular block: current practice. Anaesthesia. 2009;64(Suppl 1):22–30.CrossRefPubMedGoogle Scholar
  17. 17.
    Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS, et al. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit. Anesthesiology. 2008;109:389–98.  https://doi.org/10.1097/ALN.0b013e318182af3b.CrossRefPubMedGoogle Scholar
  18. 18.
    Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008;107:130–7.  https://doi.org/10.1213/ane.0b013e31816d1268.CrossRefPubMedGoogle Scholar
  19. 19.
    Debaene B, Plaud B, Dilly M-P, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolorazing muscle relaxant with an intermediate duration of action. Anesthesiology. 2003;98:1042–8.  https://doi.org/10.1097/00000542-200305000-00004.CrossRefPubMedGoogle Scholar
  20. 20.
    Arbous MS, Meursing AE, van Kleef JW, de Lange JJ, Spoormans HH, Touw P, et al. Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology. 2005;102:257–68.  https://doi.org/10.1097/00000542-200502000-00005.CrossRefPubMedGoogle Scholar
  21. 21.
    Asbahi M, Soto R. Dosing, monitoring, and reversal of neuromuscular blockade: are anesthesiologists following evidence-based practices? Curr Anesthesiol Rep. 2016;6:160–3.  https://doi.org/10.1007/s40140-016-0161-x.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of AnesthesiologyBeaumont HealthRoyal OakUSA

Personalised recommendations